There is no antiviral medicine to treat chikungunya viral infection. Treatment aims to alleviate symptoms through the use of pain medicine, fluids, and rest. There is no licensed vaccine to prevent ...

Valneva (VALN) announced results for its Phase 2 clinical trial evaluating the safety and immunogenicity of two different ...

Are you searching for effective medications to treat 'Chikungunya '? This comprehensive guide provides the latest information on medications-both generic and branded-that are essential for ...

Valneva’s vaccine was highly immunogenic in both dose groups. A full dose of the vaccine exhibited a more robust immune response compared to a half dose by providing protective antibody titers already ...

Valneva has shared positive results from a late-stage study of its single-dose chikungunya vaccine in adolescents aged 12 to ...

Doctors report increased post-chikungunya complaints, necessitating long-term treatment for symptoms such as post-viral arthritis and sensory disturbances. Maharashtra experienced a significant ...

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today reported further positive Phase 3 data in adolescents for its single-shot chikungunya virus (CHIKV) vaccine, IXCHIQ ® ...

The FDA is reviewing new vaccines for meningitis and chikungunya and therapies for Parkinson disease and PTSD.